v2.4.0.6

Business Segments and Geographic Information | 6 Months Ended
--- | ---
Mar. 30, 2013
Segment Reporting [Abstract] |
Business Segments and Geographic Information | (12) Business Segments and Geographic Information The Company has four reportable segments: Breast Health, Diagnostics, GYN Surgical and Skeletal Health. Certain reportable segments represent an aggregation of operating units within each segment. The Company measures and evaluates its reportable segments based on segment revenues and operating income (loss) adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, contingent consideration charges, restructuring and divestiture charges and other one-time or unusual items and related tax effects. Identifiable assets for the four principal operating segments consist of inventories, intangible assets including goodwill, and property and equipment. The Company fully allocates depreciation expense to its four reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no intersegment revenues during the three and six months ended March 30, 2013 and March 24, 2012. Segment information is as follows:
|  | Three Months Ended |  |  | Six Months Ended |
|  | March 30, 2013 |  |  | March 24, 2012 |  |  | March 30, 2013 |  |  | March 24, 2012 |
Total revenues: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Diagnostics |  | $ | 296,507 |  |  | $ | 151,841 |  |  | $ | 602,423 |  |  | $ | 305,905 |
Breast Health |  |  | 220,058 |  |  |  | 218,631 |  |  |  | 440,866 |  |  |  | 433,983 |
GYN Surgical |  |  | 73,692 |  |  |  | 77,178 |  |  |  | 154,601 |  |  |  | 155,723 |
Skeletal Health |  |  | 22,406 |  |  |  | 23,515 |  |  |  | 46,135 |  |  |  | 48,265 |
|  | $ | 612,663 |  |  | $ | 471,165 |  |  | $ | 1,244,025 |  |  | $ | 943,876 |
Operating income (loss): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Diagnostics |  | $ | (46,978 | ) |  | $ | 21,619 |  |  | $ | (32,683 | ) |  | $ | 41,757 |
Breast Health |  |  | 47,892 |  |  |  | 48,869 |  |  |  | 92,837 |  |  |  | 96,286 |
GYN Surgical |  |  | 2,241 |  |  |  | (63,377 | ) |  |  | 2,863 |  |  |  | (68,390 | )
Skeletal Health |  |  | 2,387 |  |  |  | 3,023 |  |  |  | 5,754 |  |  |  | 7,240 |
|  | $ | 5,542 |  |  | $ | 10,134 |  |  | $ | 68,771 |  |  | $ | 76,893 |
Depreciation and amortization: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Diagnostics |  | $ | 89,402 |  |  | $ | 39,926 |  |  | $ | 180,944 |  |  | $ | 79,915 |
Breast Health |  |  | 10,124 |  |  |  | 10,470 |  |  |  | 20,054 |  |  |  | 21,074 |
GYN Surgical |  |  | 26,524 |  |  |  | 26,217 |  |  |  | 53,003 |  |  |  | 52,305 |
Skeletal Health |  |  | 226 |  |  |  | 428 |  |  |  | 430 |  |  |  | 870 |
|  | $ | 126,276 |  |  | $ | 77,041 |  |  | $ | 254,431 |  |  | $ | 154,164 |
Capital expenditures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Diagnostics |  | $ | 13,464 |  |  | $ | 9,455 |  |  | $ | 27,318 |  |  | $ | 17,623 |
Breast Health |  |  | 5,910 |  |  |  | 2,213 |  |  |  | 9,490 |  |  |  | 3,782 |
GYN Surgical |  |  | 2,171 |  |  |  | 3,251 |  |  |  | 4,916 |  |  |  | 6,000 |
Skeletal Health |  |  | 28 |  |  |  | 9 |  |  |  | 206 |  |  |  | 466 |
Corporate |  |  | 2,823 |  |  |  | 2,823 |  |  |  | 4,913 |  |  |  | 5,686 |
|  | $ | 24,396 |  |  | $ | 17,751 |  |  | $ | 46,843 |  |  | $ | 33,557 |
|  | March 30, 2013 |  |  | September 29, 2012 |
Identifiable assets: |  |  |  |  |  |  |  |
Diagnostics |  | $ | 5,951,165 |  |  | $ | 6,170,553 |
Breast Health |  |  | 957,783 |  |  |  | 956,134 |
GYN Surgical |  |  | 1,898,933 |  |  |  | 1,944,386 |
Skeletal Health |  |  | 34,156 |  |  |  | 32,778 |
Corporate |  |  | 1,467,169 |  |  |  | 1,373,257 |
|  | $ | 10,309,206 |  |  | $ | 10,477,108 |
The Company had no customers with balances greater than 10% of accounts receivable as of March 30, 2013 or September 29, 2012, or any customer that represented greater than 10% of consolidated revenues during the three and six months ended March 30, 2013 and March 24, 2012. Products sold by the Company internationally are manufactured at both domestic and international locations. Transfers between the Company and its subsidiaries are generally recorded at amounts similar to the prices paid by unaffiliated foreign dealers. All intercompany profit is eliminated in consolidation. The Company operates in the major geographic areas as noted in the below chart. Revenue data is based upon customer location, and internationally totaled $153.5 million and $323.6 million during the three and six months ended March 30, 2013, respectively, and totaled $117.5 million and $235.0 million during the three and six months ended March 24, 2012, respectively. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from Germany, the United Kingdom and the Netherlands. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “All others” designation includes Canada, Latin America and the Middle East. Revenues by geography as a percentage of total revenues was as follows:
|  | Three Months Ended |  |  | Six Months Ended |
|  | March 30, 2013 |  |  | March 24, 2012 |  |  | March 30, 2013 |  |  | March 24, 2012 |
United States |  |  | 75 | % |  |  | 75 | % |  |  | 74 | % |  |  | 75 | %
Europe |  |  | 12 | % |  |  | 11 | % |  |  | 14 | % |  |  | 12 | %
Asia |  |  | 9 | % |  |  | 8 | % |  |  | 8 | % |  |  | 8 | %
All others |  |  | 4 | % |  |  | 6 | % |  |  | 4 | % |  |  | 5 | %
|  |  | 100 | % |  |  | 100 | % |  |  | 100 | % |  |  | 100 | %

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration